Sunday, 1 November 2026
MASH multimarker panels show promise, Afghanistan polio cases double, First human Shamonda virus death
- 01
Multimarker panels show promise for detecting at-risk MASH
Multimarker panels showed potential for non-invasive detection of at-risk MASH in people with metabolic dysfunction-associated steatotic liver disease (MASLD). A proteomic panel demonstrated strong diagnostic performance against histology, while individual markers had variable and limited performance. The findings could support the selection and implementation of non-invasive testing strategies and inform future guidelines, regulatory evaluation and clinical trial design. The source provides limited detail on the panels, study population and performance measures.
via The Lancet
- 02
Wild polio cases double in Afghanistan
Afghanistan has reported twice as many polio cases as in 2025. The increase has prompted concern over the Taliban’s vaccination policies. The Lancet report provides limited detail, including no case numbers or further information about those affected.
via The Lancet
- 03
First recorded human Shamonda virus case ends in death
The first recorded human infection with Shamonda virus occurred in a patient in France, who died from the infection. The virus normally affects cattle. Virologists assessed the wider public health risk as low. The source gives limited detail about the case.
via The Lancet
- 04
Trial finds no first-line benefit from prone positioning or HFOV
An international phase 3 trial found no evidence that prone positioning or high-frequency oscillatory ventilation (HFOV) as first-line strategies improved ventilator-free days in patients with early, moderate-to-severe paediatric acute respiratory distress syndrome. The trial evaluated the two strategies in a randomised, response-adaptive, two-by-two factorial design. The authors therefore did not recommend routine use of either strategy in this population. The source provides limited detail beyond the main finding and recommendation.
via The Lancet
- 05
Global analysis maps intersectional disparities in men’s health outcomes
Males had lower life expectancy and greater disability-adjusted life-years than females, with particularly poor outcomes among those in marginalised contexts. The analysis used mortality and disability-adjusted life-year data from the 1990–2023 Global Burden of Diseases, Injuries, and Risk Factors Studies. It applied an intersectional framework to examine how men’s health outcomes varied across different contexts. The source provides limited detail on specific populations, conditions or the magnitude of disparities.
via The Lancet
- 06
Marginalised men’s health remains overlooked in policy, paper argues
Men’s health receives little and uneven attention in health policy and practice despite longstanding evidence of poor health and life expectancy outcomes, according to a Lancet Men’s Health Series paper. The authors say the disparity is particularly pronounced among men who are socially or structurally marginalised. They argue that gendered and intersectional aspects of men’s health have been especially overlooked. The paper examines reasons for the lack of policy attention and proposes strategies to raise men’s health on national and global agendas, although the source gives limited detail on these strategies.
via The Lancet
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.